<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101159262</journal-id><journal-id journal-id-type="pubmed-jr-id">30202</journal-id><journal-id journal-id-type="nlm-ta">J Womens Health (Larchmt)</journal-id><journal-id journal-id-type="iso-abbrev">J Womens Health (Larchmt)</journal-id><journal-title-group><journal-title>Journal of women's health (2002)</journal-title></journal-title-group><issn pub-type="ppub">1540-9996</issn><issn pub-type="epub">1931-843X</issn></journal-meta><article-meta><article-id pub-id-type="pmid">39565225</article-id><article-id pub-id-type="pmc">11717584</article-id><article-id pub-id-type="doi">10.1089/jwh.2024.0950</article-id><article-id pub-id-type="manuscript">HHSPA2037255</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Attitudes and Experiences Regarding Communication About Maternal
Vaccination: Qualitative Findings from Non-Hispanic Black Pregnant
People</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mendez</surname><given-names>Isabel</given-names></name><degrees>MS</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Gilliard</surname><given-names>Veronica G.</given-names></name><degrees>PhD, MPH, MEd</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>Randall</surname><given-names>Laura A.</given-names></name><degrees>MPH</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Robertson</surname><given-names>Angela</given-names></name><degrees>MA</degrees><xref rid="A2" ref-type="aff">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Office of Center Communications, National Center for
Immunization and Respiratory Diseases, Centers for Disease Control and Prevention,
Atlanta, Georgia, USA.</aff><aff id="A2"><label>2</label>Immunization Services Division, National Center for
Immunization and Respiratory Diseases, Centers for Disease Control and Prevention,
Atlanta, Georgia, USA.</aff><aff id="A3"><label>3</label>Weber Shandwick Contractor, Office of Center
Communications, National Center for Immunization and Respiratory Diseases, Centers
for Disease Control and Prevention, Atlanta, Georgia, USA.</aff><author-notes><fn fn-type="equal" id="FN1"><label>*</label><p id="P1">These two authors contributed equally to this work.</p></fn><fn fn-type="con" id="FN2"><p id="P2">Authors&#x02019; Contributions</p><p id="P3">I.M.: Conceptualization, methodology, writing&#x02014;original draft
preparation, and writing&#x02014;review and editing. V.G.G.:
Conceptualization, methodology, writing&#x02014;original draft preparation,
and writing&#x02014;review and editing. L.A.R.: Project administration and
writing&#x02014;review and editing. A.R.: Writing&#x02014;review and editing
and supervision.</p></fn><corresp id="CR1">Address correspondence to: <italic toggle="yes">Isabel Mendez, MS, National
Center for Immunization and Respiratory, Disease/Office of Center
Communications, Centers for Disease Control and Prevention, 1600 Clifton Rd.
NE, H24-8, Atlanta, GA 30329-4027, USA</italic>,
<email>prz3@cdc.gov</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>5</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>20</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>1</month><year>2025</year></pub-date><volume>34</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><abstract id="ABS1"><p id="P5">Comprehensive prenatal care incorporates recommended vaccines to help
protect the mother, the pregnancy, and the infant from adverse health outcomes
and severe illness from vaccine preventable diseases (VPDs). However,
vaccinations during pregnancy remain underutilized, often influenced by concerns
about vaccine safety and low perception of disease risk. Self-reported vaccine
hesitancy among pregnant people in the United States has significantly increased
in the last few years, and influenza and Tdap (tetanus, diphtheria, and
pertussis) vaccination rates have declined. Furthermore, the number of vaccines
routinely recommended during pregnancy has expanded. Communication strategies
tailored to pregnant people may help build vaccine confidence among pregnant
people and their health care providers. While characteristics and perceptions
associated with hesitancy to vaccinate during pregnancy are documented in
existing literature, more information is needed on promising communication
practices preferred by subgroups of pregnant persons, particularly Black
pregnant people who have higher rates of illness from VPDs and greater risk of
pregnancy-related complications. This article summarizes literature on the
current landscape of prenatal vaccination, discusses qualitative findings from
focus groups with non-Hispanic Black pregnant people, and describes promising
practices for communicating with this group about vaccination. Promising
practices include specifying the benefits of vaccination for both the pregnant
person and the infant, outlining potential risks, and emphasizing the overall
importance of vaccination during pregnancy, while also acknowledging that many
non-Hispanic Black pregnant people may have health concerns they perceive as
superseding vaccination.</p></abstract><kwd-group><kwd>maternal health</kwd><kwd>maternal vaccination</kwd><kwd>health disparities</kwd><kwd>health communication</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>Introduction</title><p id="P6">Comprehensive prenatal care incorporates immunization to prevent and mitigate
the impact of vaccine preventable diseases (VPDs) for the pregnant person, fetus,
and newborn.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Yet, uptake of
Advisory Committee on Immunization Practices (ACIP) recommended maternal vaccines
remains low.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup> Low vaccination coverage leaves many pregnant
people and their infants susceptible to VPDs and associated serious adverse maternal
or perinatal consequences.<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref></sup></p><p id="P7">Self-reported hesitancy about influenza vaccines among pregnant people
increased from 17.5% in 2019&#x02013;2020 to 24.7% in 2022&#x02013;2023.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Similarly, self-reported hesitancy
among pregnant people about tetanus, diphtheria, and pertussis (Tdap) vaccines
increased from 15.1% during 2019&#x02013;2020 to 19.8% in 2022&#x02013;2023.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> While characteristics associated
with hesitancy to vaccinate during pregnancy are documented in existing literature,
there is more to learn about promising communication practices that can improve
vaccine confidence among groups of pregnant people experiencing low vaccination
coverage.<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup> Coverage estimates indicate that overall
vaccination coverage among non-Hispanic Black pregnant people remains suboptimal. As
of April 2023, 31.4% of non-Hispanic Black pregnant women received a Tdap vaccine
during the 2022&#x02013;2023 flu season compared with 62.2% of non-Hispanic White
pregnant women.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> As of January
2024, 10.3% of non-Hispanic Black pregnant people received a maternal respiratory
syncytial virus (RSV) vaccine (does not include nirsevimab coverage of infants)
compared with 19.9% of non-Hispanic White pregnant people.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> Cumulative monthly influenza vaccination
coverage data indicate that only 21.5% of non-Hispanic Black pregnant people are
estimated to have received a 2023&#x02013;2024 influenza vaccine as of March 2024
compared with 37.1% of non-Hispanic White pregnant people.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> As of May 2024, coverage estimates indicate
that 5.9% of non-Hispanic Black pregnant people have received a 2023&#x02013;2024
COVID-19 vaccine compared with 17.3% of non-Hispanic White pregnant
people.<sup><xref rid="R11" ref-type="bibr">11</xref></sup> Understanding
that non-Hispanic Black pregnant people are less likely to report receiving
respectful maternity care than pregnant people from other observed racial and ethnic
groups,<sup><xref rid="R12" ref-type="bibr">12</xref></sup> it is important
to recognize that there are many factors that may impact the low vaccination
coverage observed within this population. As recommendations for vaccination during
pregnancy continue to expand, it is important for public health practitioners to
utilize communication practices that remain responsive to the evolving sociocultural
factors that may influence vaccination behaviors during pregnancy.<sup><xref rid="R13" ref-type="bibr">13</xref></sup></p><p id="P8">Black and biracial pregnant people have reported utilizing self-protective
actions within their reproductive health care, often citing the legacy of scientific
racism and reproductive health inequities.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref></sup> Self-protective
actions were described as &#x0201c;seeking a health care professional of color,
overpreparing for appointments, enlisting advocates, seeking care only when
desperate, and heightening symptoms to be heard.&#x0201d;<sup><xref rid="R15" ref-type="bibr">15</xref></sup> What is less understood is how Black
pregnant people&#x02019;s utilization of self-protective actions and lived
experiences with reproductive racism may influence vaccine communication preferences
and decision-making.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> In 2023,
the Centers for Disease Control and Prevention (CDC) sponsored 12 focus groups to
increase understanding of the views of pregnant people regarding their experiences
with prenatal care and receiving maternal vaccinations. Of the 12 focus groups, 6
were entirely composed of non-Hispanic Black pregnant people to explore how
self-protective actions may influence communication needs and preferences related to
vaccination during pregnancy.</p><p id="P9">Some research suggests that tailored communication materials may help
increase vaccine confidence among pregnant people.<sup><xref rid="R17" ref-type="bibr">17</xref>&#x02013;<xref rid="R21" ref-type="bibr">21</xref></sup> This article briefly synthesizes peer-reviewed literature on
the current landscape of maternal vaccination uptake and discusses findings from
CDC&#x02019;s formative research to summarize recommendations and promising practices
for cultivating culturally responsive communications about vaccination with
non-Hispanic Black pregnant people amid increasing nationwide vaccine hesitancy.</p><sec id="S2"><title>Review of literature on vaccine uptake during pregnancy</title><p id="P10">The PubMed database was searched between October 2023 and August 2024
using the following terms: &#x0201c;Tdap,&#x0201d; OR &#x0201c;influenza,&#x0201d;
OR &#x0201c;RSV,&#x0201d; OR &#x0201c;COVID-19,&#x0201d; AND
&#x0201c;pregnant&#x0201d; AND &#x0201c;acceptance.&#x0201d; Additional
topic-specific searches, such as evidence from communication interventions
focused on prenatal vaccination, were performed, as needed. We included articles
published in English between 2018 and 2024 and selected 32 articles that
supported communication recommendations related to vaccination during
pregnancy.</p><p id="P11">Three important findings from existing literature can be applied to
promising communication practices on vaccination during pregnancy. First, while
vaccine safety is a common concern,<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup> pregnant
people may have attitudes that vary by vaccine.<sup><xref rid="R24" ref-type="bibr">24</xref></sup> Reasons for these discrepancies vary,
but existing literature provides insights on factors associated with vaccine
acceptance<sup><xref rid="R25" ref-type="bibr">25</xref></sup>&#x02014;by
vaccine.<sup><xref rid="R26" ref-type="bibr">26</xref></sup> For
example, Tdap vaccines are often more readily accepted by pregnant people than
influenza vaccines.<sup><xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R27" ref-type="bibr">27</xref>,<xref rid="R28" ref-type="bibr">28</xref></sup> The influenza vaccine is considered by some to be
undesirable, in part, due to beliefs that the vaccine would make them
sick.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> In addition,
there are concerns regarding the influenza vaccine&#x02019;s safety for their
unborn child and questions about safety and efficacy given annual changes in the
vaccine&#x02019;s composition.<sup><xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R28" ref-type="bibr">28</xref></sup> Safety
concerns are also commonly raised about the perceived novelty of recently
recommended vaccines. Black and Hispanic pregnant people may have low knowledge
of COVID-19 mRNA vaccine technology,<sup><xref rid="R29" ref-type="bibr">29</xref></sup> which could impact vaccine attitudes. Several pregnant
people have also cited concerns about the perceived speed of the development of
the COVID-19 vaccine as part of their decision to decline the
vaccination.<sup><xref rid="R30" ref-type="bibr">30</xref></sup>
Nonacceptance of COVID-19 vaccines may be higher among White, Black, and
Hispanic pregnant people compared with Asian pregnant people.<sup><xref rid="R31" ref-type="bibr">31</xref></sup> Among those who were pregnant
or currently trying to become pregnant, perception of illness was a strong
predictor of RSV vaccination intent.<sup><xref rid="R32" ref-type="bibr">32</xref></sup> Among pregnant people, attributes such as perceived
vaccine effectiveness in protecting babies against serious illness requiring
medical attention because of RSV and perceived improvements in the duration of
protection against severe illness during RSV season were influential motivators
toward maternal RSV vaccination.<sup><xref rid="R33" ref-type="bibr">33</xref></sup></p><p id="P12">The second finding relates to how provider practices may impact
vaccination uptake. For example, non-Hispanic Black pregnant people may be less
likely to receive a provider vaccination offer than pregnant people from other
racial and ethnic groups.<sup><xref rid="R34" ref-type="bibr">34</xref>&#x02013;<xref rid="R36" ref-type="bibr">36</xref></sup> In
addition, provider care setting may play a role in vaccination uptake as
vaccination coverage in teaching practices may be higher than in private
practices, which may be related to vaccine stock and availability.<sup><xref rid="R37" ref-type="bibr">37</xref></sup> Provider hesitancy to strongly
recommend and offer prenatal vaccines may also influence vaccination uptake.
Knowledge gaps, limited time, increased politicization surrounding the topic of
vaccination, concerns about vaccine safety and efficacy, unmet desires for
additional data, perceptions around disease risk, and distrust of government and
health care systems have all been suggested as potential contributors to
provider vaccination hesitancy.<sup><xref rid="R38" ref-type="bibr">38</xref>&#x02013;<xref rid="R42" ref-type="bibr">42</xref></sup>
Providers may also be hesitant to re-counsel patients who decline vaccination,
deferring to individualized interpretations of respect for patient autonomy,
particularly within communities experiencing persistent health
inequities.<sup><xref rid="R43" ref-type="bibr">43</xref></sup> The
perceived importance of the vaccine recommendation can also be an important
factor. For example, some Spanish-speaking rural populations expressed that
their provider did not openly encourage or discuss vaccination, which
contributed to barriers.<sup><xref rid="R44" ref-type="bibr">44</xref></sup>
This challenge between patient autonomy and provider hesitancy remains
particularly relevant to uptake because a provider recommendation is one of the
strongest known facilitators toward vaccination for pregnant people.<sup><xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R45" ref-type="bibr">45</xref>&#x02013;<xref rid="R48" ref-type="bibr">48</xref></sup></p><p id="P13">The third finding relates to the influence of information sources for
appropriately tailored communication products from trusted messengers, which can
help facilitate vaccination acceptance.<sup><xref rid="R17" ref-type="bibr">17</xref>&#x02013;<xref rid="R21" ref-type="bibr">21</xref></sup>
Pregnant people demonstrate high levels of information seeking
behavior.<sup><xref rid="R23" ref-type="bibr">23</xref></sup> Again, it
is important to remember that subgroups of pregnant people often have different
preferences for communication practices. For example, within rural populations,
some English-speaking pregnant people preferred social media communication
products that feature a peer messenger,<sup><xref rid="R49" ref-type="bibr">49</xref></sup> whereas some Spanish-speaking pregnant people preferred
a health care provider or other culturally trusted messengers.<sup><xref rid="R44" ref-type="bibr">44</xref></sup></p></sec><sec id="S3"><title>Insights on maternal vaccination from formative research with non-Hispanic
Black pregnant people</title><p id="P14">CDC sponsored 12 virtual focus groups between February 21, 2023 and
March 2, 2023. The purpose of these focus groups was to increase understanding
of the views of pregnant people, particularly non-Hispanic Black pregnant
people, regarding their experiences with prenatal care and receiving maternal
vaccinations, and to gather feedback on messages regarding the importance of
vaccination during pregnancy. Focus groups were segmented into six groups of
general population pregnant people and six groups of non-Hispanic Black pregnant
people. Groups were further segmented by whether it was the participant&#x02019;s
first pregnancy or second or higher pregnancy. This report will focus on
qualitative findings from the 33 participants in the 6 all non-Hispanic Black
focus groups. Participants were 18&#x02013;49 years of age and currently pregnant
in their second or third trimester. Focus groups lasted approximately 90 minutes
and were conducted in English. All sessions were audio recorded, transcribed
verbatim, and de-identified for analysis. This project was determined to be a
nonresearch program evaluation and, therefore, did not require institutional
review board approval.</p><p id="P15">Focus group discussions explored several health domains with
non-Hispanic Black pregnant people. This report will highlight selected themes
that relate to their experiences and perceptions related to maternal vaccination
and preferred sources and methods of communication as follows: (1) trusted
sources of information for health-related pregnancy questions, (2) the substance
and format of vaccination conversations with prenatal care providers, and (3)
maternal vaccination communication preferences.</p></sec></sec><sec id="S4"><title>Results</title><sec id="S5"><title>Trusted sources of information for health-related pregnancy questions</title><p id="P16">Participants described their process of searching for information
related to their health during their pregnancy. Most participants described
independently utilizing electronic search engines. These searches were often
driven by symptoms or topics related to expectations for different stages of
their pregnancy. Several participants described taking information from the
internet and fact checking it with their health care providers, particularly if
their provider was Black or African American. Participants often triangulated
health information that they found online with personal narratives from lived
experiences of other pregnant people, doulas, and health care providers, often
as reported through social media. Many participants described an increase in
perceived trust among these messengers, particularly when a shared identity such
as race, a similar due date, or a comparable co-occurring health condition was
present. Most participants did not express a preference for celebrities or
narratives from someone of a particular acclaim; instead, value was placed on
hearing from everyday peers, doulas of color (preferably Black and African
American), and health care providers of color (preferably female and Black or
African American). For many, digital forums, pregnancy apps, videos, and
in-person support groups provided community and highly valued access to peer
experiences, provider perspectives, and advocacy insights from doulas. In
addition, several participants had friends or family members who worked in the
health care system who often served as additional trusted sources of information
within participant&#x02019;s triangulation processes. Many participants also
expressed comfort with contacting their health care providers through patient
portals or phone calls when they needed additional information on health
questions related to their pregnancy, particularly when the need for the
information was perceived as time sensitive. In addition, participants often
cited that their providers referred them to the American College of
Obstetricians and Gynecologists website for additional information.</p></sec><sec id="S6"><title>Substance and format of vaccination conversations with prenatal care
providers</title><p id="P17">Several participants described encountering the topic of vaccination
with their health care provider. However, many of those participants did not
consider the encounter a conversation, and instead, participants often recounted
simply being asked if they wanted to receive the vaccination or being told they
should receive the vaccination. Consequently, many participants described being
offered a vaccination that was not preceded by a recommendation or a rationale.
Some described that this lack of rationale signaled to them that the vaccination
was not important, and others described that without a recommendation, the
vaccination offer reinforced the feeling of receiving generic depersonalized
care.</p><p id="P18">Attitudes surrounding the prioritization of vaccination also varied
among participants by the pregnant person&#x02019;s work setting. For example,
several participants who worked from home perceived themselves to be at low risk
of acquiring illnesses, and therefore, many felt less inclined to get
vaccinated, whereas several participants who worked with the public described
sentiments of increased risk, which often motivated them toward vaccination and
subsequent conversations with their prenatal care provider. Individuals with
preexisting health conditions, such as those living with asthma, also described
a distinct motivation to get vaccinated.</p></sec><sec id="S7"><title>Maternal vaccination communication preferences</title><p id="P19">Four messages designed to promote recommended vaccinations during
pregnancy were tested among participants (<xref rid="T1" ref-type="table">Table
1</xref>). Many participants were aware of the concept of vaccinations
producing antibodies that pass protection between the pregnant person and their
baby. Several participants were also aware that changes to their immune system
could increase their likelihood of severe illness during their pregnancy. Due to
this existing knowledge, some felt that statements that simply reiterated the
risk of severe illness provided little motivation to action or no new
information. When this occurred, several participants described the messaging as
lacking a specific rationale, which often prompted a neutral feeling and limited
engagement.</p><p id="P20">Participants expressed appreciation for short statements (30 words or
less) with a clear call to action. While some did not feel it was specific
enough, the call to action to speak with a trusted health care professional
about vaccination was well received, in part, because it reinforced the autonomy
of the pregnant person and was perceived as invitational as opposed to
directive. Statements that reinforced the protective benefits of vaccination for
the baby were also well received. It is notable that some participants described
that the appeal of protection for the baby had less to do with emotion and was
more attributed to a technical expression of how vaccines work through a clear
description of the benefits of vaccination during pregnancy. In addition,
although protection for the baby was an important motivator, some participants
reiterated that the pregnant person is the individual who will consent to and
receive the vaccination; therefore, there was interest and value in brief
descriptions of protective benefits for both the pregnant person and their
baby.</p><p id="P21">Several participants expressed that care should be taken with language
to avoid equating the act of vaccination as an expression of love or a
demonstration of desire to protect one&#x02019;s baby. For some, labeling or
implying vaccination as an act of love or a demonstration of desire to protect
one&#x02019;s baby induced guilt and shame for those who were undecided or
uninterested in vaccination during their pregnancy. Alternatively, many
participants reinforced the importance of language that acknowledged the context
of the sensitivity of a pregnant person striving to make appropriate health
decisions for themselves and their developing baby. Relatedly, many participants
described emotional statements as off-putting and preferred informative
statements that did not have an explicit emotional pull. Mentions of death and
hospitalization were often described as triggering, although these words did
prompt a few participants to want to learn more about the referenced VPD.
However, these inquiries were often from the perspective of fact-checking the
severity of the claim.</p><p id="P22">Several participants expressed interest in messaging that outlined both
the benefits and potential risks of vaccination during pregnancy. Some
participants viewed language that was perceived as overtly pro-vaccination as
dismissive of the lived experiences of mistreatment and discrimination endured
by some non-Hispanic Black pregnant people within the U.S. health care system,
which sometimes prompted disengagement with the message altogether. Most
participants also preferred messages that either detailed or led them to concise
information about recommended timing for the administration of each routinely
recommended vaccine during their pregnancy.</p><p id="P23">One tested statement used the gender-neutral language of
<italic toggle="yes">pregnant people</italic> as opposed to <italic toggle="yes">pregnant
women</italic>. Most participants were tolerant of the gender-neutral
language describing it as &#x0201c;more inclusive&#x0201d; than gendered language.
However, some participants remarked that gender-neutral language resulted in the
communication feeling more indirect than if gendered language was used, leaving
some participants with the sentiment that the intended audience was less
defined. Some participants did directly prefer gendered
language&#x02014;expressing their gender as an important identity within their
pregnancy journey.</p></sec><sec id="S8"><title>Development of From Me, To You communications</title><p id="P24">Building upon findings from this formative research, CDC developed
<italic toggle="yes">From Me, To You</italic>&#x02014;a tailored communications effort
with resources in both English and Spanish&#x02014;designed to invite English-
and Spanish-speaking Black pregnant people into a conversation with health care
providers that they trust to discuss prenatal vaccination. <italic toggle="yes">From Me, To
You</italic> embodies a four-part strategic approach.</p><p id="P25">First, this effort strives to counter the status quo of negative
narratives around Black maternal health and vaccination during pregnancy with
positive storytelling and illustrations of joy among Black pregnant people and
their support networks.</p><p id="P26">Second, this effort strives to learn from and support messengers
identified as trusted by the community of focus to bring conversations about
vaccination during pregnancy into more spaces where Black pregnant people are
already receiving information. For example, in addition to CDC-owned channels,
messaging was bolstered through paid partnerships with digital communities
identified as trusted by our intended audience. These spaces, which foster
community among expectant parents and Black women, are equipped to encourage
conversations around vaccination during pregnancy in their own authentic
voices.</p><p id="P27">Third, understanding that the parental instinct to protect one&#x02019;s
child is often a strong motivator, this effort strives to encourage
conversations about how vaccines help pregnant people share protection with
their babies.</p><p id="P28">Fourth, understanding that non-Hispanic Black pregnant people may be
less likely to receive a vaccination offer from their provider compared with
pregnant people from other racial and ethnic groups,<sup><xref rid="R34" ref-type="bibr">34</xref>&#x02013;<xref rid="R36" ref-type="bibr">36</xref></sup> this effort includes intentional outreach to prenatal
care providers to support them as they make recommendations, offers, and
referrals.</p><p id="P29"><italic toggle="yes">From Me, To You</italic> includes several curated resources that
have been tested with our intended audience. Available resources include fact
sheets on recommended vaccines during pregnancy, in-office posters, short
videos, and graphics designed for social media. Information on vaccine safety,
provider toolkits, draft patient portal reminder language, and vaccine-specific
coverage estimates among pregnant people are also available. For more
information on <italic toggle="yes">From Me, To You</italic> visit <ext-link xlink:href="http://www.cdc.gov/vaccines/php/from-me-to-you/index.html" ext-link-type="uri">www.cdc.gov/vaccines/php/from-me-to-you/index.html</ext-link></p><p id="P30">There were several limitations present in this project. Focus groups
were conducted only in English, which may have influenced participation for
non-Hispanic Black pregnant people who primarily speak languages other than
English. Each focus group represented a small convenience sample, and findings
cannot be generalized to non-Hispanic Black pregnant people overall. In
addition, perspectives of prenatal care providers were not included due to time
and resource limitations. However, to our knowledge, this is one of few projects
specifically focused on the prenatal vaccination communication needs and
preferences of non-Hispanic Black pregnant people. While additional research is
needed, this project offers valuable insights into this population&#x02019;s
vaccine decision-making experiences.</p></sec></sec><sec id="S9"><title>Conclusion</title><p id="P31">Prenatal vaccination is at an important juncture: (1) the number of ACIP
recommended vaccines for pregnant people has expanded,<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup> (2)
racial disparities in vaccination coverage among non-Hispanic Black pregnant people
persist,<sup><xref rid="R6" ref-type="bibr">6</xref>&#x02013;<xref rid="R11" ref-type="bibr">11</xref></sup> and (3) measures indicate that nationwide
vaccine hesitancy among pregnant people is increasing.<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R34" ref-type="bibr">34</xref></sup> In
response to these timely concerns, promising practices related to tailored
communication strategies that aim to build vaccine confidence among non-Hispanic
Black pregnant people and prenatal care providers are proposed below.</p><p id="P32">Patient&#x02013;provider conversations about vaccination during pregnancy may
consider pathways to elevate the urgency and importance of vaccines, while
acknowledging that some non-Hispanic Black pregnant people may have overriding
health concerns they perceive as superseding vaccination. While many competing
health concerns are not explicitly related to vaccination, it is essential for
communicators to increase understanding of the broader context in which non-Hispanic
Black pregnant people are making vaccination decisions. Tailored communication
products that include information on the pathogenesis of specific VPDs, guidance on
when pregnant people should get vaccinated, and a brief, but specific, explanation
of the benefits of vaccination for both the pregnant person and their baby may be
particularly motivating toward vaccination. Communication products that address
common concerns around vaccine safety and potential short-term side effects may also
increase vaccine confidence among non-Hispanic Black pregnant people.</p><p id="P33">Communications on vaccination during pregnancy may also consider
opportunities to account for lived experiences of non-Hispanic Black patients that
may include distrust in vaccinations and negative experiences with health care.
Collaborating with trusted voices, including doulas, midwives, community health
workers, and those with a similar racial and/or ethnic background as the audience of
focus, to develop and test messaging may increase the resonance of communication
products designed to promote vaccination during pregnancy.</p><p id="P34">Outreach to health care providers may consider pathways to incorporate the
lived realities of providers in the aftermath of the end of the COVID-19 public
health emergency declaration. Time limitations, knowledge gaps related to evolving
guidance on newly recommended vaccines, increased politicization surrounding the
topic of vaccination, and unmet desires for additional safety and efficacy data
remain intersecting factors that may influence provider engagement with vaccination
conversations with pregnant people. Equipping providers with up-to-date resources
and information to guide conversations around common questions related to specific
vaccines may increase health care provider confidence and likelihood to engage in
vaccine conversations with their pregnant patients. Because a health care provider
recommendation is one of the strongest predictors of vaccination during
pregnancy,<sup><xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R45" ref-type="bibr">45</xref>&#x02013;<xref rid="R48" ref-type="bibr">48</xref></sup> provider training and continuing education outreach may
consider pathways to revisit the components of a strong vaccination recommendation
during pregnancy, including any warranted changes in approach since the onset of the
COVID-19 pandemic. It may be beneficial for providers to precede a vaccination offer
or referral with both a rationale and recommendation. Providers may also consider
connecting patients to additional resources about each recommended vaccine one to
two appointments before the recommended timing for administration. As practitioners
increase understanding of the communication needs and preferences of non-Hispanic
Black pregnant people, culturally responsive communication products will be helpful
tools in addressing health inequities.</p></sec></body><back><fn-group><fn fn-type="COI-statement" id="FN3"><p id="P35">Author Disclosure Statement</p><p id="P36">No competing financial interests exist.</p></fn><fn id="FN4"><p id="P37">Disclaimer</p><p id="P38">In this report, &#x0201c;maternal&#x0201d; is used at times to align with
referenced data. The authors recognize that all pregnant people may not identify
with gendered language. The findings and conclusions in this report are those of
the authors and do not necessarily represent the official position of the
CDC.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><article-title>ACOG Committee Opinion No.
741: Maternal Immunization</article-title>. <source>Obstet Gynecol</source>
<year>2018</year>;<volume>131</volume>(<issue>6</issue>):<fpage>e214</fpage>&#x02013;<lpage>e217</lpage>;
doi: <pub-id pub-id-type="doi">10.1097/AOG.0000000000002662</pub-id><pub-id pub-id-type="pmid">29794683</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="book"><source>Guidelines for Vaccinating Pregnant Persons</source>. <publisher-name>Centers for Disease Control and
Prevention</publisher-name>. <date-in-citation>Updated July 12,
2024</date-in-citation>. Available from: <comment><ext-link xlink:href="https://www.cdc.gov/vaccines-pregnancy/hcp/vaccination-guidelines/index.html" ext-link-type="uri">https://www.cdc.gov/vaccines-pregnancy/hcp/vaccination-guidelines/index.html</ext-link></comment>
[<date-in-citation>Last accessed: September 6,
2024</date-in-citation>].</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="book"><source>ACIP Vaccine Recommendations and Guidelines</source>. <publisher-name>Centers for Disease Control and
Prevention</publisher-name>. <date-in-citation>Updated July 18,
2024</date-in-citation>. Available from: <comment><ext-link xlink:href="https://www.cdc.gov/acip-recs/hcp/vaccine-specific/?CDC_AAref_Val=https://www.cdc.gov/vaccines/hcp/acip-recs/index.html" ext-link-type="uri">https://www.cdc.gov/acip-recs/hcp/vaccine-specific/?CDC_AAref_Val=https://www.cdc.gov/vaccines/hcp/acip-recs/index.html</ext-link></comment>
[<date-in-citation>Last accessed: September 6,
2024</date-in-citation>].</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Mor</surname><given-names>G</given-names></name>, <name><surname>Cardenas</surname><given-names>I</given-names></name>. <article-title>The immune system in pregnancy: Aunique
complexity</article-title>. <source>Am J Reprod Immunol</source>
<year>2010</year>;<volume>63</volume>(<issue>6</issue>):<fpage>425</fpage>&#x02013;<lpage>433</lpage>;
doi: <pub-id pub-id-type="doi">10.1111/j.1600-0897.2010.00836.x</pub-id><pub-id pub-id-type="pmid">20367629</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Racicot</surname><given-names>K</given-names></name>, <name><surname>Kwon</surname><given-names>JY</given-names></name>, <name><surname>Aldo</surname><given-names>P</given-names></name>, <etal/>
<article-title>Understanding the complexity of the immune system during
pregnancy</article-title>. <source>Am J Reprod Immunol</source>
<year>2014</year>;<volume>72</volume>(<issue>2</issue>):<fpage>107</fpage>&#x02013;<lpage>116</lpage>;
doi: <pub-id pub-id-type="doi">10.1111/aji.12289</pub-id><pub-id pub-id-type="pmid">24995526</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Razzaghi</surname><given-names>H</given-names></name>, <name><surname>Kahn</surname><given-names>KE</given-names></name>, <name><surname>Calhoun</surname><given-names>K</given-names></name>, <etal/>
<article-title>Influenza, Tdap, and COVID-19 vaccination coverage and hesitancy
among pregnant women - United States, April 2023</article-title>.
<source>MMWR Morb Mortal Wkly Rep</source>
<year>2023</year>;<volume>72</volume>(<issue>39</issue>):<fpage>1065</fpage>&#x02013;<lpage>1071</lpage>;
doi: <pub-id pub-id-type="doi">10.15585/mmwr.mm7239a4</pub-id><pub-id pub-id-type="pmid">37768879</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Razai</surname><given-names>MS</given-names></name>, <name><surname>Mansour</surname><given-names>R</given-names></name>, <name><surname>Ravindran</surname><given-names>P</given-names></name>, <etal/>
<article-title>Facilitators and barriers to vaccination uptake in pregnancy: A
qualitative systematic review</article-title>. <source>PLoS One</source>
<year>2024</year>;<volume>19</volume>(<issue>4</issue>):<fpage>e0298407</fpage>;
doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0298407</pub-id><pub-id pub-id-type="pmid">38640190</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Nichol</surname><given-names>B</given-names></name>, <name><surname>McCready</surname><given-names>JL</given-names></name>, <name><surname>Steen</surname><given-names>M</given-names></name>, <etal/>
<article-title>Barriers and facilitators of vaccine hesitancy for COVID-19,
influenza, and pertussis during pregnancy and in mothers of infants under
two years: An umbrella review</article-title>. <source>PLoS One</source>
<year>2023</year>;<volume>18</volume>(<issue>3</issue>):<fpage>e0282525</fpage>;
doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0282525</pub-id><pub-id pub-id-type="pmid">36862698</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="book"><source>Respiratory Syncytial Virus (RSV) Vaccination Coverage, Pregnant Persons, United States</source>.
<publisher-name>Centers for Disease Control and Prevention</publisher-name>.
<date-in-citation>Updated March 6, 2024</date-in-citation>. Available from:
<comment><ext-link xlink:href="https://www.cdc.gov/vaccines/imz-managers/coverage/rsvvaxview/pregnant-persons-coverage-intent.html" ext-link-type="uri">https://www.cdc.gov/vaccines/imz-managers/coverage/rsvvaxview/pregnant-persons-coverage-intent.html</ext-link></comment>
[<date-in-citation>Last accessed: July 25,
2024</date-in-citation>].</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="book"><source>Influenza Vaccination Coverage, Pregnant Persons, United States</source>. <publisher-name>Centers for
Disease Control and Prevention</publisher-name>. <date-in-citation>Updated
April 26, 2024</date-in-citation>. Available from: <comment><ext-link xlink:href="https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-coverage-pregnant.html" ext-link-type="uri">https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-coverage-pregnant.html</ext-link></comment>
[<date-in-citation>Last accessed: July 25,
2024</date-in-citation>].</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="book"><source>Pregnant Persons Coverage</source>.
<publisher-name>Centers for Disease Control and Prevention</publisher-name>
<comment>Available from</comment>: <comment><ext-link xlink:href="https://www.cdc.gov/vaccines/imz-managers/coverage/covidvaxview/interactive/pregnant-coverage-vaccination.html" ext-link-type="uri">https://www.cdc.gov/vaccines/imz-managers/coverage/covidvaxview/interactive/pregnant-coverage-vaccination.html</ext-link></comment>
[<date-in-citation>Last accessed: July 25,
2024</date-in-citation>].</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Mohamoud</surname><given-names>YA</given-names></name>, <name><surname>Cassidy</surname><given-names>E</given-names></name>, <name><surname>Fuchs</surname><given-names>E</given-names></name>, <etal/>
<article-title>Vital signs: Maternity care experiences - United States, April
2023</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>
<year>2023</year>;<volume>72</volume>(<issue>35</issue>):<fpage>961</fpage>&#x02013;<lpage>967</lpage>;
doi: <pub-id pub-id-type="doi">10.15585/mmwr.mm7235e1</pub-id><pub-id pub-id-type="pmid">37651304</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Boulet</surname><given-names>SL</given-names></name>, <name><surname>Stanhope</surname><given-names>KK</given-names></name>, <name><surname>DeSantis</surname><given-names>C</given-names></name>, <etal/>
<article-title>A descriptive study of maternal vaccination uptake, attitudes,
and beliefs in pregnancy among persons delivering at an Urban Safety Net
Hospital</article-title>. <source>Womens Health Rep (New Rochelle)</source>
<year>2023</year>;<volume>4</volume>(<issue>1</issue>):<fpage>288</fpage>&#x02013;<lpage>297</lpage>;
doi: <pub-id pub-id-type="doi">10.1089/whr.2023.0032</pub-id><pub-id pub-id-type="pmid">37363358</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>De Genna</surname><given-names>NM</given-names></name>, <name><surname>Hossain</surname><given-names>F</given-names></name>, <name><surname>Dwarakanath</surname><given-names>M</given-names></name>, <etal/>
<article-title>Pandemic stressors and vaccine hesitancy among young, pregnant
Black people: A qualitative study of health disparities during a global
pandemic</article-title>. <source>Birth Defects Res</source>
<year>2023</year>;<volume>115</volume>(<issue>20</issue>):<fpage>1912</fpage>&#x02013;<lpage>1922</lpage>;
doi: <pub-id pub-id-type="doi">10.1002/bdr2.2262</pub-id><pub-id pub-id-type="pmid">37807480</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Treder</surname><given-names>K</given-names></name>, <name><surname>White</surname><given-names>KO</given-names></name>, <name><surname>Woodhams</surname><given-names>E</given-names></name>, <etal/>
<article-title>Racism and the reproductive health experiences of U.S.-Born Black
Women</article-title>. <source>Obstet Gynecol</source>
<year>2022</year>;<volume>139</volume>(<issue>3</issue>):<fpage>407</fpage>&#x02013;<lpage>416</lpage>;
doi: <pub-id pub-id-type="doi">10.1097/AOG.0000000000004675</pub-id><pub-id pub-id-type="pmid">35115434</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Avorgbedor</surname><given-names>F</given-names></name>, <name><surname>Gondwe</surname><given-names>KW</given-names></name>, <name><surname>Aljarrah</surname><given-names>A</given-names></name>, <etal/>
<article-title>COVID-19 vaccine decision-making among black pregnant and
postpartum women</article-title>. <source>J Racial Ethn Health Disparities</source>
<year>2024</year>;<volume>11</volume>(<issue>4</issue>):<fpage>2073</fpage>&#x02013;<lpage>2082</lpage>;
doi: <pub-id pub-id-type="doi">10.1007/s40615-023-01675-6</pub-id><pub-id pub-id-type="pmid">37335424</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Eppes</surname><given-names>EV</given-names></name>, <name><surname>Augustyn</surname><given-names>M</given-names></name>, <name><surname>Gross</surname><given-names>SM</given-names></name>, <etal/>
<article-title>Engagement with and acceptability of digital media platforms for
use in improving health behaviors among vulnerable families: Systematic
review</article-title>. <source>J Med Internet Res</source>
<year>2023</year>;<volume>25</volume>:<fpage>e40934</fpage>; doi:
<pub-id pub-id-type="doi">10.2196/40934</pub-id><pub-id pub-id-type="pmid">36735286</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Hallas</surname><given-names>D</given-names></name>, <name><surname>Altman</surname><given-names>S</given-names></name>, <name><surname>Mandel</surname><given-names>E</given-names></name>, <etal/>
<article-title>Vaccine hesitancy in prenatal women and mothers of newborns:
Results of an interventional study</article-title>. <source>Nurse Pract</source>
<year>2023</year>;<volume>48</volume>(<issue>3</issue>):<fpage>36</fpage>&#x02013;<lpage>47</lpage>;
doi: <pub-id pub-id-type="doi">10.1097/01.NPR.0000000000000018</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Parsons</surname><given-names>J</given-names></name>, <name><surname>Griffiths</surname><given-names>SE</given-names></name>, <name><surname>Thomas</surname><given-names>N</given-names></name>, <etal/>
<article-title>How effective are digital interventions in increasing flu
vaccination among pregnant women? A systematic review and
meta-analysis</article-title>. <source>J Public Health (Oxf)</source>
<year>2022</year>;<volume>44</volume>(<issue>4</issue>):<fpage>863</fpage>&#x02013;<lpage>876</lpage>;
doi: <pub-id pub-id-type="doi">10.1093/pubmed/fdab220</pub-id><pub-id pub-id-type="pmid">34164686</pub-id>
</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Salmon</surname><given-names>DA</given-names></name>, <name><surname>Dudley</surname><given-names>MZ</given-names></name>, <name><surname>Brewer</surname><given-names>J</given-names></name>, <etal/>
<article-title>LetsTalkShots: Personalized vaccine risk communication [published
correction appears in Front Public Health. 2023 Oct
30;11:1311055]</article-title>. <source>Front Public Health</source>
<year>2023</year>;<volume>11</volume>:<fpage>1311055</fpage>; doi:
<pub-id pub-id-type="doi">10.3389/fpubh.2023.1195751</pub-id><pub-id pub-id-type="pmid">38026293</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Ellingson</surname><given-names>MK</given-names></name>, <name><surname>Dudley</surname><given-names>MZ</given-names></name>, <name><surname>Limaye</surname><given-names>RJ</given-names></name>, <etal/>
<article-title>Enhancing uptake of influenza maternal vaccine</article-title>.
<source>Expert Rev Vaccines</source>
<year>2019</year>;<volume>18</volume>(<issue>2</issue>):<fpage>191</fpage>&#x02013;<lpage>204</lpage>;
doi: <pub-id pub-id-type="doi">10.1080/14760584.2019.1562907</pub-id><pub-id pub-id-type="pmid">30587042</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Mitchell</surname><given-names>SL</given-names></name>, <name><surname>Schulkin</surname><given-names>J</given-names></name>, <name><surname>Power</surname><given-names>ML</given-names></name>. <article-title>Vaccine hesitancy in pregnant women: A narrative
review</article-title>. <source>Vaccine</source>
<year>2023</year>;<volume>41</volume>(<issue>29</issue>):<fpage>4220</fpage>&#x02013;<lpage>4227</lpage>;
doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2023.05.047</pub-id><pub-id pub-id-type="pmid">37291023</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Rand</surname><given-names>CM</given-names></name>, <name><surname>Olson-Chen</surname><given-names>C</given-names></name>. <article-title>Maternal vaccination and vaccine
hesitancy</article-title>. <source>Pediatr Clin North Am</source>
<year>2023</year>;<volume>70</volume>(<issue>2</issue>):<fpage>259</fpage>&#x02013;<lpage>269</lpage>;doi:
<pub-id pub-id-type="doi">10.1016/j.pcl.2022.11.004</pub-id><pub-id pub-id-type="pmid">36841594</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Battarbee</surname><given-names>AN</given-names></name>, <name><surname>Stockwell</surname><given-names>MS</given-names></name>, <name><surname>Varner</surname><given-names>M</given-names></name>, <etal/>
<article-title>Attitudes toward COVID-19 illness and COVID-19 vaccination among
pregnant women: A cross-sectional multicenter study during August-December
2020</article-title>. <source>Am J Perinatol</source>
<year>2022</year>;<volume>39</volume>(<issue>1</issue>):<fpage>75</fpage>&#x02013;<lpage>83</lpage>;
doi: <pub-id pub-id-type="doi">10.1055/s-0041-1735878</pub-id><pub-id pub-id-type="pmid">34598291</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Lutz</surname><given-names>CS</given-names></name>, <name><surname>Carr</surname><given-names>W</given-names></name>, <name><surname>Cohn</surname><given-names>A</given-names></name>, <etal/>
<article-title>Understanding barriers and predictors of maternal immunization:
Identifying gaps through an exploratory literature review</article-title>.
<source>Vaccine</source>
<year>2018</year>;<volume>36</volume>(<issue>49</issue>):<fpage>7445</fpage>&#x02013;<lpage>7455</lpage>;
doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.10.046</pub-id><pub-id pub-id-type="pmid">30377064</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Coleman</surname><given-names>MA</given-names></name>, <name><surname>Dongarwar</surname><given-names>D</given-names></name>, <name><surname>Ramirez</surname><given-names>J</given-names></name>, <etal/>
<article-title>Factors impacting vaccine uptake during pregnancy: A
retrospective analysis</article-title>. <source>Int J MCH AIDS</source>
<year>2022</year>;<volume>11</volume>(<issue>2</issue>):<fpage>e554</fpage>;
doi: <pub-id pub-id-type="doi">10.21106/ijma.554</pub-id><pub-id pub-id-type="pmid">36258713</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Strassberg</surname><given-names>ER</given-names></name>, <name><surname>Power</surname><given-names>M</given-names></name>, <name><surname>Schulkin</surname><given-names>J</given-names></name>, <etal/>
<article-title>Patient attitudes toward influenza and tetanus, diphtheria and
acellular pertussis vaccination in pregnancy</article-title>.
<source>Vaccine</source>
<year>2018</year>;<volume>36</volume>(<issue>30</issue>):<fpage>4548</fpage>&#x02013;<lpage>4554</lpage>;
doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.05.121</pub-id><pub-id pub-id-type="pmid">29907484</pub-id>
</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>O&#x02019;Leary</surname><given-names>ST</given-names></name>, <name><surname>Riley</surname><given-names>LE</given-names></name>, <name><surname>Lindley</surname><given-names>MC</given-names></name>, <etal/>
<article-title>Obstetrician-gynecologists&#x02019; strategies to address vaccine
refusal among pregnant women</article-title>. <source>Obstet Gynecol</source>
<year>2019</year>;<volume>133</volume>(<issue>1</issue>):<fpage>40</fpage>&#x02013;<lpage>47</lpage>;
doi: <pub-id pub-id-type="doi">10.1097/AOG.0000000000003005</pub-id><pub-id pub-id-type="pmid">30531564</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Bonilla</surname><given-names>E</given-names></name>, <name><surname>Fogel</surname><given-names>J</given-names></name>, <name><surname>Hubley</surname><given-names>R</given-names></name>, <etal/>
<article-title>Survey of COVID-19 vaccine attitudes in predominately minority
pregnant women</article-title>. <source>South Med J</source>
<year>2023</year>;<volume>116</volume>(<issue>8</issue>):<fpage>677</fpage>&#x02013;<lpage>682</lpage>;
doi: <pub-id pub-id-type="doi">10.14423/SMJ.0000000000001587</pub-id><pub-id pub-id-type="pmid">37536694</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Golder</surname><given-names>S</given-names></name>, <name><surname>McRobbie-Johnson</surname><given-names>ACE</given-names></name>, <name><surname>Klein</surname><given-names>A</given-names></name>, <etal/>
<article-title>Social media and COVID-19 vaccination hesitancy during pregnancy:
A mixed methods analysis</article-title>. <source>BJOG</source>
<year>2023</year>;<volume>130</volume>(<issue>7</issue>):<fpage>750</fpage>&#x02013;<lpage>758</lpage>;
doi: <pub-id pub-id-type="doi">10.1111/1471-0528.17481</pub-id><pub-id pub-id-type="pmid">37078279</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>A</given-names></name>, <name><surname>Puglisi</surname><given-names>JL</given-names></name>, <name><surname>Patel</surname><given-names>S</given-names></name>, <etal/>
<article-title>COVID-19 vaccine acceptance in pregnant women in the United
States: A systematic review and meta-analysis</article-title>. <source>J Womens Health (Larchmt)</source>
<year>2024</year>;<volume>33</volume>(<issue>4</issue>):<fpage>453</fpage>&#x02013;<lpage>466</lpage>;
doi: <pub-id pub-id-type="doi">10.1089/jwh.2023.0498</pub-id><pub-id pub-id-type="pmid">38112561</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Saper</surname><given-names>JK</given-names></name>, <name><surname>Heffernan</surname><given-names>M</given-names></name>, <name><surname>Simon</surname><given-names>NE</given-names></name>, <etal/>
<article-title>RSV vaccination intention among people who are or plan to become
pregnant</article-title>. <source>Pediatrics</source>
<year>2024</year>;<volume>153</volume>(<issue>5</issue>):<fpage>e2023065140</fpage>;
doi: <pub-id pub-id-type="doi">10.1542/peds.2023-065140</pub-id><pub-id pub-id-type="pmid">38660734</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Maculaitis</surname><given-names>MC</given-names></name>, <name><surname>Hauber</surname><given-names>B</given-names></name>, <name><surname>Beusterien</surname><given-names>KM</given-names></name>, <etal/>
<article-title>A latent class analysis of factors influencing preferences for
infant respiratory syncytial virus (RSV) preventives among pregnant people
in the United States</article-title>. <source>Hum Vaccin Immunother</source>
<year>2024</year>;<volume>20</volume>(<issue>1</issue>):<fpage>2358566</fpage>;
doi: <pub-id pub-id-type="doi">10.1080/21645515.2024.2358566</pub-id><pub-id pub-id-type="pmid">38847198</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Razzaghi</surname><given-names>H</given-names></name>, <name><surname>Kahn</surname><given-names>KE</given-names></name>, <name><surname>Black</surname><given-names>CL</given-names></name>, <etal/>
<article-title>Influenza and Tdap vaccination coverage among pregnant
women&#x02014;United States, April 2020</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>
<year>2020</year>;<volume>69</volume>(<issue>39</issue>):<fpage>1391</fpage>&#x02013;<lpage>1397</lpage>;
doi: <pub-id pub-id-type="doi">10.15585/mmwr.mm6939a2</pub-id><pub-id pub-id-type="pmid">33001873</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Kortsmit</surname><given-names>K</given-names></name>, <name><surname>Oduyebo</surname><given-names>T</given-names></name>, <name><surname>Simeone</surname><given-names>RM</given-names></name>, <etal/>
<article-title>Influenza and tetanus, diphtheria, and acellular pertussis
vaccination coverage during pregnancy: Pregnancy risk assessment monitoring
system, 2020</article-title>. <source>Public Health Rep</source>
<year>2024</year>;<volume>139</volume>(<issue>2</issue>):<fpage>218</fpage>&#x02013;<lpage>229</lpage>;
doi: <pub-id pub-id-type="doi">10.1177/00333549231179252</pub-id><pub-id pub-id-type="pmid">37386826</pub-id>
</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Arnold</surname><given-names>LD</given-names></name>, <name><surname>Luong</surname><given-names>L</given-names></name>, <name><surname>Rebmann</surname><given-names>T</given-names></name>, <etal/>
<article-title>Racial disparities in U.S. maternal influenza vaccine uptake:
Results from analysis of Pregnancy Risk Assessment Monitoring System (PRAMS)
data, 2012&#x02013;2015</article-title>. <source>Vaccine</source>
<year>2019</year>;<volume>37</volume>(<issue>18</issue>):<fpage>2520</fpage>&#x02013;<lpage>2526</lpage>;
doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.02.014</pub-id><pub-id pub-id-type="pmid">30928172</pub-id>
</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Martinez</surname><given-names>CL</given-names></name>, <name><surname>McLaren</surname><given-names>RA</given-names></name>, <name><surname>Narayanamoorthy</surname><given-names>S</given-names></name>, <etal/>
<article-title>Rates of influenza and Tdap vaccination in teaching and private
obstetrical practices, and the influence of vaccine
hesitancy</article-title>. <source>Matern Child Health J</source>
<year>2023</year>;<volume>27</volume>(<issue>7</issue>):<fpage>1272</fpage>&#x02013;<lpage>1276</lpage>;
doi: <pub-id pub-id-type="doi">10.1007/s10995-023-03660-1</pub-id><pub-id pub-id-type="pmid">36995649</pub-id>
</mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Lbrecht</surname><given-names>D</given-names></name>
<article-title>Vaccination, politics and COVID-19 impacts</article-title>.
<source>BMC Public Health</source>
<year>2022</year>;<volume>22</volume>(<issue>1</issue>):<fpage>96</fpage>; doi:
<pub-id pub-id-type="doi">10.1186/s12889-021-12432-x</pub-id><pub-id pub-id-type="pmid">35031053</pub-id>
</mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Chervenak</surname><given-names>FA</given-names></name>, <name><surname>McCullough</surname><given-names>LB</given-names></name>, <name><surname>Gr&#x000fc;nebaum</surname><given-names>A</given-names></name>. <article-title>Reversing physician hesitancy to recommend COVID-19
vaccination for pregnant patients</article-title>. <source>Am J Obstet Gynecol</source>
<year>2022</year>;<volume>226</volume>(<issue>6</issue>):<fpage>805</fpage>&#x02013;<lpage>812</lpage>;
doi: <pub-id pub-id-type="doi">10.1016/j.ajog.2021.11.017</pub-id><pub-id pub-id-type="pmid">34762864</pub-id>
</mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Peterson</surname><given-names>CJ</given-names></name>, <name><surname>Lee</surname><given-names>B</given-names></name>, <name><surname>Nugent</surname><given-names>K</given-names></name>. <article-title>COVID-19 vaccination hesitancy among healthcare
workers-A review</article-title>. <source>Vaccines (Basel)</source>
<year>2022</year>;<volume>10</volume>(<issue>6</issue>):<fpage>948</fpage>; doi:
<pub-id pub-id-type="doi">10.3390/vaccines10060948</pub-id><pub-id pub-id-type="pmid">35746556</pub-id>
</mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Ricc&#x000f2;</surname><given-names>M</given-names></name>, <name><surname>Vezzosi</surname><given-names>L</given-names></name>, <name><surname>Balzarini</surname><given-names>F</given-names></name>, <etal/>
<article-title>Vaccines are underused in pregnancy: What about knowledge,
attitudes and practices of providers?</article-title>
<source>Acta Biomed</source>
<year>2020</year>;<volume>91</volume>(<issue>3-S)</issue>:<fpage>55</fpage>&#x02013;<lpage>62</lpage>;
doi: <pub-id pub-id-type="doi">10.23750/abm.v91i3-S.9442</pub-id><pub-id pub-id-type="pmid">32275268</pub-id>
</mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>C</given-names></name>, <name><surname>Mullen</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>D</given-names></name>, <etal/>
<article-title>Healthcare providers&#x02019; vaccine perceptions, hesitancy, and
recommendation to patients: A systematic review</article-title>.
<source>Vaccines (Basel)</source>
<year>2021</year>;<volume>9</volume>(<issue>7</issue>):<fpage>713</fpage>; doi:
<pub-id pub-id-type="doi">10.3390/vaccines9070713</pub-id><pub-id pub-id-type="pmid">34358132</pub-id>
</mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><name><surname>Rodriguez</surname><given-names>GF</given-names></name>, <name><surname>Vilari&#x000f1;o</surname><given-names>V</given-names></name>, <name><surname>Agasse</surname><given-names>E</given-names></name>, <etal/>
<article-title>Vaccination in pregnancy: Healthcare provider attitudes and
practices</article-title>. <source>Int J Gynaecol Obstet</source>
<year>2023</year>;<volume>162</volume>(<issue>1</issue>):<fpage>58</fpage>&#x02013;<lpage>69</lpage>;
doi: <pub-id pub-id-type="doi">10.1002/ijgo.14572</pub-id></mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>Sanchez</surname><given-names>M</given-names></name>, <name><surname>Martel</surname><given-names>I</given-names></name>, <name><surname>Cox</surname><given-names>E</given-names></name>, <etal/>
<article-title>Factors influencing COVID-19 vaccine uptake among
Spanish-speaking pregnant people</article-title>. <source>Vaccines (Basel)</source>
<year>2023</year>;<volume>11</volume>(<issue>11</issue>):<fpage>1726</fpage>;
doi: <pub-id pub-id-type="doi">10.3390/vaccines11111726</pub-id><pub-id pub-id-type="pmid">38006058</pub-id>
</mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><name><surname>Kiefer</surname><given-names>MK</given-names></name>, <name><surname>Mehl</surname><given-names>R</given-names></name>, <name><surname>Costantine</surname><given-names>MM</given-names></name>, <etal/>
<article-title>Association between social vulnerability and influenza and
tetanus-diphtheria-acellular pertussis vaccination in pregnant and
postpartum individuals</article-title>. <source>Am J Obstet Gynecol MFM</source>
<year>2022</year>;<volume>4</volume>(<issue>3</issue>):<fpage>100603</fpage>;
doi: <pub-id pub-id-type="doi">10.1016/j.ajogmf.2022.100603</pub-id><pub-id pub-id-type="pmid">35240346</pub-id>
</mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><name><surname>Spires</surname><given-names>B</given-names></name>, <name><surname>Brewton</surname><given-names>A</given-names></name>, <name><surname>Maples</surname><given-names>JM</given-names></name>, <etal/>
<article-title>Vaccine hesitancy in women&#x02019;s health</article-title>.
<source>Obstet Gynecol Clin North Am</source>
<year>2023</year>;<volume>50</volume>(<issue>2</issue>):<fpage>401</fpage>&#x02013;<lpage>419</lpage>;
doi: <pub-id pub-id-type="doi">10.1016/j.ogc.2023.02.013</pub-id><pub-id pub-id-type="pmid">37149319</pub-id>
</mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><name><surname>Wales</surname><given-names>DP</given-names></name>, <name><surname>Khan</surname><given-names>S</given-names></name>, <name><surname>Suresh</surname><given-names>D</given-names></name>, <etal/>
<article-title>Factors associated with Tdap vaccination receipt during
pregnancy: A cross-sectional study</article-title>. <source>Public Health</source>
<year>2020</year>;<volume>179</volume>:<fpage>38</fpage>&#x02013;<lpage>44</lpage>;
doi: <pub-id pub-id-type="doi">10.1016/j.puhe.2019.10.001</pub-id><pub-id pub-id-type="pmid">31726399</pub-id>
</mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal"><name><surname>Zimmerman</surname><given-names>M</given-names></name>, <name><surname>Zapata</surname><given-names>LP</given-names></name>, <name><surname>Bachiller</surname><given-names>K</given-names></name>, <etal/>
<article-title>Comparison of attitudes toward routine maternal vaccines and
COVID-19 vaccines among pregnant patients in an urban safety-net
setting</article-title>. <source>J Natl Med Assoc</source>
<year>2023</year>;<volume>115</volume>(<issue>4</issue>):<fpage>362</fpage>&#x02013;<lpage>376</lpage>;
doi: <pub-id pub-id-type="doi">10.1016/j.jnma.2023.04.003</pub-id><pub-id pub-id-type="pmid">37210252</pub-id>
</mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal"><name><surname>Cox</surname><given-names>E</given-names></name>, <name><surname>Sanchez</surname><given-names>M</given-names></name>, <name><surname>Baxter</surname><given-names>C</given-names></name>, <etal/>
<article-title>COVID-19 vaccine hesitancy among English-speaking pregnant women
living in rural Western United States</article-title>. <source>Vaccines (Basel)</source>
<year>2023</year>;<volume>11</volume>(<issue>6</issue>):<fpage>1108</fpage>;
doi: <pub-id pub-id-type="doi">10.3390/vaccines11061108</pub-id><pub-id pub-id-type="pmid">37376496</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1.</label><caption><p id="P39">Message Testing Statements by Preferred Message Count,
<italic toggle="yes">n</italic> = 33</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Statement</th><th align="center" valign="top" rowspan="1" colspan="1">Count</th></tr><tr><th align="left" valign="top" colspan="2" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Protect yourself and your baby. Talk to a
trusted health care professional about getting flu and whooping cough
vaccines during pregnancy.</td><td align="center" valign="top" rowspan="1" colspan="1">14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Whooping cough is a serious disease that can
be deadly for babies. Getting a Tdap<sup><xref rid="TFN1" ref-type="table-fn">a</xref></sup> vaccine during pregnancy
gives babies protection against whooping cough before they&#x02019;re
even born.</td><td align="center" valign="top" rowspan="1" colspan="1">8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A pregnant person can protect themselves and
pass on critical disease protection to their baby before it is born.
Vaccines have been given during pregnancy for decades to help protect
pregnant people and their babies from diseases that can be serious in
newborns, like flu and whooping cough.</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pregnant people are at higher risk of serious
illness and complications, including hospitalization, from flu.
Vaccination during pregnancy can help protect you and your baby.</td><td align="center" valign="top" rowspan="1" colspan="1">5</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>a</label><p id="P40">Tdap (tetanus, diphtheria, and pertussis).</p></fn></table-wrap-foot></table-wrap></floats-group></article>